1. Home
  2. MDWD vs REI Comparison

MDWD vs REI Comparison

Compare MDWD & REI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • REI
  • Stock Information
  • Founded
  • MDWD 2000
  • REI 2004
  • Country
  • MDWD Israel
  • REI United States
  • Employees
  • MDWD N/A
  • REI N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • REI Oil & Gas Production
  • Sector
  • MDWD Health Care
  • REI Energy
  • Exchange
  • MDWD Nasdaq
  • REI Nasdaq
  • Market Cap
  • MDWD 208.2M
  • REI 241.9M
  • IPO Year
  • MDWD 2014
  • REI N/A
  • Fundamental
  • Price
  • MDWD $20.13
  • REI $0.75
  • Analyst Decision
  • MDWD Strong Buy
  • REI
  • Analyst Count
  • MDWD 2
  • REI 0
  • Target Price
  • MDWD $35.00
  • REI N/A
  • AVG Volume (30 Days)
  • MDWD 58.5K
  • REI 4.7M
  • Earning Date
  • MDWD 08-13-2025
  • REI 08-06-2025
  • Dividend Yield
  • MDWD N/A
  • REI N/A
  • EPS Growth
  • MDWD N/A
  • REI N/A
  • EPS
  • MDWD N/A
  • REI 0.36
  • Revenue
  • MDWD $19,213,000.00
  • REI $335,642,768.00
  • Revenue This Year
  • MDWD $20.64
  • REI $2.59
  • Revenue Next Year
  • MDWD $25.71
  • REI $17.45
  • P/E Ratio
  • MDWD N/A
  • REI $2.10
  • Revenue Growth
  • MDWD N/A
  • REI N/A
  • 52 Week Low
  • MDWD $14.14
  • REI $0.72
  • 52 Week High
  • MDWD $22.51
  • REI $2.05
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 53.36
  • REI 44.22
  • Support Level
  • MDWD $19.73
  • REI $0.75
  • Resistance Level
  • MDWD $20.97
  • REI $0.83
  • Average True Range (ATR)
  • MDWD 0.71
  • REI 0.04
  • MACD
  • MDWD 0.06
  • REI -0.00
  • Stochastic Oscillator
  • MDWD 57.08
  • REI 14.91

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About REI Ring Energy Inc.

Ring Energy Inc is an independent exploration and production company based in The Woodlands, Texas and is engaged in oil and natural gas development, production, acquisition, and exploration activities currently focused in the Permian Basin of Texas. The drilling operations of the company target the oil and liquid rich producing formations in the Northwest Shelf, the Central Basin Platform and the Delaware Basin all of which are part of the Permian Basin in Texas.

Share on Social Networks: